This report is being submitted retrospectively as part of internal review.A review of the device's manufacturing records revealed that the sensor lot met all requirements including sterilization requirements for release.The sensor is inserted by making a small incision and placing it under skin and potential for developing skin irritation/swelling/pain/ inflammation/infection around the insertion site is a known anticipated adverse event.The sensor was inserted on (b)(6) 2023.The customer first noticed symptoms (warmth, pus, and slight pain at the insertion site) on (b)(6) 2023 (day 67 of sensor life).The system asserted a sensor replacement alert and retired the sensor the next day, (b)(6) 2023.The customer scheduled an appointment for the same day to have the sensor removed and get a new sensor inserted.When the customer visited the hcp's office on (b)(6) 2023, the hcp examined the site and confirmed infection at the site of the retired sensor.The sensor was removed was inserted with another eversense e3 sensor.The customer is doing fine and does not have further issues.No further investigation was found necessary for this complaint.
|
Senseonics was made aware of an incident where the patient's hcp observed and confirmed infection at the insertion site during the time of removal of the sensor, on (b)(6) 2023.The customer first noticed (experienced) the symptoms on (b)(6) 2023.The site of infection was hot and the patient had little pain and pus around the sensor.After the sensor was removed, the patient had no more pain and felt well.
|